COVID-19 Policy Statement
Review

Knowledge Center

Agrochemical Case Study

Violation of Licensing Agreement Revealed with In-Product Brand Protection Program

The Issue

An agricultural chemical manufacturer suspected that one of its formulators was in violation of a licensing agreement, substituting a generic active ingredient for the licensed component. The formulator also appeared to be diverting the end-product for sale in a region outside of its licensed territory where it had a higher value.

The Solution

The manufacturer turned to Authentix for a solution to ensure the use of their component in the formulator’s end-product. Authentix worked with the manufacturer to incorporate US FDA-compliant in-product markers into the licensed component, ensuring that the markers could endure the harsh synthesis process, become homogenous and remain stable, while not impacting the active ingredient. By adding markers to all of the licensed component, a test of the suspect formulator’s end-product that showed low concentration or no marker presence would indicate that the formulator was replacing the licensed active ingredient with a generic product.

The markers are detectable in the field using a simple qualitative (yes / no) test kit, backed up with a quantitative laboratory test. The layered marker program allows wide-spread and quick field screening, with suspect samples sent to a centralized laboratory for validation and to provide support for corrective action. The manufacturer’s personnel were trained to use the test kits and perform the laboratory analysis, allowing them to monitor the formulator’s end-product for compliance with the licensing agreement.

The Outcome

The agricultural chemical manufacturer determined conclusively that the formulator was in violation of its licensing agreement by testing for and not finding the Authentix markers in the end-product. Field tests were confirmed by precise laboratory testing, delivering proof that enabled enforcement action to be taken.

Download the PDF


COVID-19 Policy Statement


v1.06.01.2021

At Authentix, our mission to safeguard the integrity of global commerce is our priority as we continue to focus on customer needs with the challenges presented by the COVID-19 pandemic. Our corporate leadership team continues to monitor the situation closely and its potential impact on supply chain continuity.

Our first and foremost commitment is to the health and safety of all Authentix employees. As we have said when faced with other similar infectious disease situations, we will never force Authentix employees to travel to geographic areas where they are uncomfortable or that present an increased risk of exposure to infectious disease.

Effective June 1, 2021, we have reopened our Addison Texas Facility to all Authentix personnel. We continue to follow the CDC guidelines and protocol and continue to require that all customers, vendors or suppliers support these efforts and for those who present themselves at Authentix locations to respect and adhere to our policies and procedures.

We will continue to communicate regularly with our suppliers and updating contingency plans to ensure against any adverse impact or disruption to our customers, acknowledging that we are however subject to continued government restrictions and limited availability of transportation that may continue during this time. We encourage you to reach out to your Authentix point of contact with any questions or concerns.

ONSITE GUEST WAIVER

Back To Top